The purification of extracellular vesicles (EVs) remains a major hurdle in the progression of fundamental research and the commercial...
Read More »EXOSOME NEWS
Researchers develop hybrid sensor that can help diagnose cancer
A team of researchers from HSE University, Skoltech, MPGU, and MISIS have developed a nanophotonic-microfluidic sensor whose potential applications include cancer detection, monitoring and treatment..
Read More »Engineering extracellular vesicles by three-dimensional dynamic culture of hMSC
Human mesenchymal stem cell (hMSC) derived extracellular vesicles (EVs) have shown therapeutic potential in recent studies. However, the corresponding therapeutic components are largely unknown, and scale-up production of hMSC EVs ...
Read More »A bimodal liquid biopsy for cancer immunotherapy
Despite its high potential, PD-L1 expressed by tumors has not been successfully utilized as a biomarker for estimating treatment responses to immunotherapy. Circulating tumor cells and...
Read More »Extracellular vesicles in cancer therapy
Extracellular vesicles (EVs), including a variety of membrane-enclosed nanosized particles carrying cell-derived cargo, mediate a major type of intercellular communication in physiological and...
Read More »Researchers use extracellular vesicles for therapy of Parkinson’s disease
Extracellular vesicles (EVs) are cell-derived nanoparticles that facilitate transport of proteins, lipids, and genetic material, playing important roles in intracellular communication. They have remarkable potential as non-toxic and non-immunogenic...
Read More »Liquid biopsies and future of cancer treatment
ASCO’s attendees witnessed a heightened focus on liquid biopsies, the noninvasive blood tests that detect multiple types of cancer, often at early stages as well as show whether or not a cancer has...
Read More »Coya Therapeutics Secures Option Agreement for Exclusive Worldwide Rights to Exosome Engineering Technology from Carnegie Mellon University
Coya Therapeutics announced the execution of an option agreement for exclusive worldwide rights to a novel and proprietary technology platform enabling...
Read More »UK study identifies therapeutic targets for Alzheimer’s disease
A new University of Kentucky College of Medicine study has identified potential targets to develop a therapy that could prevent Alzheimer’s disease. Alzheimer’s disease is the most common...
Read More »Featured Exosome Job – Scientist, Regenerative Medicine – Exosomes
Contribute to our expanding range of translational preventive and regenerative medicine work with exosomes from different source cells, including iPSCs and many iPSC-derived cell types like MSCs, HSCs,...
Read More »Jobs
-
Post-doc Position Available – Cancer and Infectious Disease Biomarkers
The Postdoctoral Fellow for the Department of Biochemistry and Molecular Biology will be responsible for molecular biology and bioengineering-based new technologies and approaches to detect and measure biomarkers associated...
Read More » -
Featured Exosomes Job – Production Specialist In Extracellular Vesicles
-
Featured Exosome Job – Assistant Professor/Associate Professor/Professor – Exosome Biology, Biomimetics and Immunotherapy
-
PhD Opportunity – Stem Cell Exosomes – Important Communicators with Therapeutic Potential in the Dental Pulp
-
Post-doc position available – Faculty of Dentistry
Industry News
-
Biological Dynamics, Perlmutter Cancer Center at NYU Langone Health collaborate on pancreatic cancer research
Study to investigate effectiveness of early-stage pancreatic cancer detection using patented exosome-isolation technology Biological Dynamics, a company commercializing its exosome-isolation ExoVerita™ platform, announced a collaboration with the Perlmutter Cancer Center ...
Read More » -
Creative Biolabs: Wishing a Year of Prosperity for Exosome Studies
-
NeuroDex receives MJFF grant to study blood test for Parkinson’s stratification based on extracellular vesicles
-
MDimune announces a collaboration with Hanyang University on the projects selected through the 3rd BioDrone™ Award
-
$3.0m CRC-P grant to VivaZome Therapeutics and Partners for Customised Exosome Therapy